{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antilles",
      "West Indies",
      "bronchiolite",
      "bronchiolitis",
      "climat tropical",
      "infections respiratoires par le virus syncytial",
      "palivizumab",
      "respiratory syncytial virus infections",
      "tropical climate"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "D\u00e9crire les virus impliqu\u00e9s, la saisonnalit\u00e9 et la coinfection chez les enfants hospitalis\u00e9s avec une suspicion de bronchiolite. M\u00c9THODES: Au cours de la p\u00e9riode du 01/07/2007 au 31/12/2008, tous les enfants hospitalis\u00e9s pour bronchiolite dans le service de p\u00e9diatrie ont \u00e9t\u00e9 prospectivement inclus et soumis \u00e0 un d\u00e9pistage du virus respiratoire syncytial (VRS). Nous avons test\u00e9 r\u00e9trospectivement tous les \u00e9chantillons pour RSVA, RSVB, rhinovirus (RV), m\u00e9tapneumovirus humain, Parainfluenza 1, 2, 3, 4, Influenza A, et Influenza B. R\u00c9SULTATS: 198 enfants ont \u00e9t\u00e9 test\u00e9s et 23% \u00e9taient n\u00e9gatifs pour tous les virus. RSVA \u00e9tait pr\u00e9dominant en 2008 (64% de tous les virus) et RSVB en 2007 (66% de tous les virus). RV \u00e9tait fr\u00e9quent pendant les deux saisons (24% de tous les virus). La grippe n'a pas \u00e9t\u00e9 trouv\u00e9e pendant la p\u00e9riode d'\u00e9tude. La distribution des virus \u00e9tait similaire quelle que soit la saison ou l'\u00e2ge, et identique aux mod\u00e8les typiques dans les pays temp\u00e9r\u00e9s. Les coinfections \u00e9taient moins fr\u00e9quentes que dans les r\u00e9gions temp\u00e9r\u00e9es car les saisons virales respiratoires semblent mieux s\u00e9par\u00e9es. La saison des bronchiolites a commenc\u00e9 en ao\u00fbt et s'est termin\u00e9e en d\u00e9cembre avec un pic en octobre.",
        "La saisonnalit\u00e9 sp\u00e9cifique de l'infection bronchiolite n\u00e9cessite une prophylaxie au palivizumab d\u00e9butant en juillet pour les nourrissons \u00e0 haut risque."
      ],
      "CopyrightInformation": "\u00a9 2020 John Wiley & Sons Ltd."
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32628347",
  "DateCompleted": {
    "Year": "2021",
    "Month": "03",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "03",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "08",
        "Day": "05"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/tmi.13462"
    ],
    "Journal": {
      "ISSN": "1365-3156",
      "JournalIssue": {
        "Volume": "25",
        "Issue": "10",
        "PubDate": {
          "Year": "2020",
          "Month": "Oct"
        }
      },
      "Title": "Tropical medicine & international health : TM & IH",
      "ISOAbbreviation": "Trop Med Int Health"
    },
    "ArticleTitle": "Seasonality and coinfection of bronchiolitis: epidemiological specificity and consequences in terms of prophylaxis in tropical climate.",
    "Pagination": {
      "StartPage": "1291",
      "EndPage": "1297",
      "MedlinePgn": "1291-1297"
    },
    "Abstract": {
      "AbstractText": [
        "To describe the viruses involved, seasonality and coinfection in hospitalised children with suspected bronchiolitis.",
        "Over the period 1/07/2007 to 31/12/2008, all children hospitalised for bronchiolitis in the paediatric ward were prospectively included, and had respiratory syncytial virus (RSV) screenings. We retrospectively tested all samples for RSVA, RSVB, rhinovirus (RV), human metapneumovirus, parainfluenza 1, 2, 3, 4, influenza A and influenza B.",
        "198 children were tested, and 23% were negative for all viruses. RSVA was predominant in 2008 (64% of all viruses) and RSVB in 2007 (66% of all viruses). RV was frequent during both seasons (24% of all viruses). Flu was not found during the study period. Virus distribution was similar regardless of season or age, and identical to typical patterns in temperate countries. Coinfections were less frequent than in temperate regions because respiratory virus seasons seem to be better separated. The bronchiolitis season started in August and finished in December with a peak in October.",
        "The specific seasonality of bronchiolitis infection requires palivizumab prophylaxis starting in early July for high-risk infants."
      ],
      "CopyrightInformation": "\u00a9 2020 John Wiley & Sons Ltd."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Virology Department, University Hospital of Martinique, Martinique, France."
          }
        ],
        "LastName": "Najioullah",
        "ForeName": "Fatiha",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Virology Department, University Hospital of Martinique, Martinique, France."
          }
        ],
        "LastName": "Bancons",
        "ForeName": "Pierre",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Virology Department, University Hospital of Martinique, Martinique, France."
          }
        ],
        "LastName": "C\u00e9saire",
        "ForeName": "Raymond",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Virology Department, University Hospital of Martinique, Martinique, France."
          },
          {
            "Identifier": [],
            "Affiliation": "Pediatric and Neonatal Intensive Care Department, University Hospital of Martinique, Martinique, France."
          }
        ],
        "LastName": "Fl\u00e9chelles",
        "ForeName": "Olivier",
        "Initials": "O"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Trop Med Int Health",
    "NlmUniqueID": "9610576",
    "ISSNLinking": "1360-2276"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "DQ448MW7KS",
      "NameOfSubstance": "Palivizumab"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Bronchiolitis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Hospitalized"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Coinfection"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Longitudinal Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Martinique"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Palivizumab"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prospective Studies"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "virology"
      ],
      "DescriptorName": "Respiratory Syncytial Virus Infections"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Respiratory Syncytial Virus, Human"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Retrospective Studies"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Rhinovirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Seasons"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tropical Climate"
    }
  ]
}